Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protocol to analyze the role of various metabolites in impacting global RNA 5-methylcytosine levels in cultured cells by dot blot

STAR Protocols(2024)10.1016/j.xpro.2023.102815Source: DataRank Database

Protocol to analyze the role of various metabolites in impacting global RNA 5-methylcytosine levels in cultured cells by dot blot is a research paper published in STAR Protocols (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Hui‐Kuan Lin ORCID,Tingjin Chen ORCID

Live enrichment

PubMed:38180832 PMC:PMC10801338 OpenAlex:https://openalex.org/W4390597926

NCI

Grant: R01CA248037

NCI

Grant: R01CA256158

NCI

Grant: R01CA270617

National Institutes of Health

Grant: 5R01CA270617-04

Identification of a novel targetable cancer stem cell regulator promoting cancer progression and metastasis in non-small cell lung cancer

National Institutes of Health

Grant: 7R01CA248037-03

Regulation of oncogenic Akt ubiquitination and activation by diverse mechanisms in cancer

National Institutes of Health

Grant: 5R01CA256158-05

Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xpro.2023.102815

GOLDhttps://doi.org/10.1016/j.xpro.2023.102815

publisherhttps://doi.org/10.1016/j.xpro.2023.102815

publisherhttps://api.elsevier.com/content/article/PII:S2666166723007827?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166723007827?httpAccept=text/plain

Fields of Study

RNA modifications and cancerCancer-related molecular mechanisms researchRNA and protein synthesis mechanismsMedicineBiologyChemistry0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

RNAStaining and LabelingImmunoblotting5-Methylcytosine

Keywords

RNAWestern blotDot blotProtocol (science)Molecular biology5-MethylcytosineStainingBlotChemistryBiologyComputational biologyBiochemistryDNAGene expressionGeneticsGeneMedicinePathologyDNA methylationMetabolismCancerQ1-390Science (General)Staining and LabelingImmunoblottingProtocol

Sustainable Development Goals

SDG 0: Zero hunger